Internet-based writing therapy for the treatment of depressive symptoms in the Arabic-speaking world - A randomized controlled trial

Phase 1

Recruiting

• Conditions: F32; F33; F34.1; Depressive episode; Recurrent depressive disorder; Dysthymia

• Registration Number: DRKS00016652
• Lead Sponsor: Zentrum Überleben gGmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-02-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Arabic-speaking
Criteria for a current major depressive episode or for a persistent depressive disorder according to DSM-5 (American Psychiatric Association, 2013) are fulfilled
Access to the Internet and a computer
Private email address

Exclusion Criteria

Significant, current suicidal tendencies
Severe depressive symptoms (BDI-II = 45)
Symptoms too low (BDI-II 0-13)
Criteria for post-traumatic stress disorder according to DSM-5 (American Psychiatric Association, 2013) are fulfilled
Bipolar symptoms
Psychotic symptoms
Increased alcohol, drug or substance use within the last year
Concurrent psychotherapeutic treatment
Concurrent treatment with psychopharmaceuticals with unstable dose (changes in dose/type of medication in the last 4 weeks)
Previous depression treatment by the Ilajnafsy programme

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in depressive symptoms: Patient Health Questionnaire (PHQ-9) <br>Times of measurement: Baseline; 4 intermediate measurements during th intervention; post-treatment; follow-up (3- and 6-week follow-up)<br><br>Changes in depressive symptoms: Beck Depression Inventory II (BDI-II) <br>Times of measurement: Baseline; post-treatment; follow-up (3- and 6-week follow-up)